TrialEuropean journal of clinical pharmacology2016

Telmisartan increases systemic exposure to rosuvastatin after single and multiple doses, and in vitro studies show telmisartan inhibits ABCG2-mediated transport of rosuvastatin.

Miao Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.